Characteristics and treatment results of refractory and relapsed acute myeloid leukaemia in paediatric patients treated in Polish Paediatric Leukaemia/Lymphoma Study Group institutions according to the Protocol Acute Myeloid Leukaemia BerlinFrankfurt-Munster 2012 and a review of novel treatment possibilities in paediatric acute myeloid leukaemia

被引：0

作者：

Samborska, Magdalena ^{[1
,18
]}

Skalska-Sadowska, Jolanta ^{[1
]}

Achkar, Robert ^{[2
]}

Wachowiak, Jacek ^{[1
]}

Derwich, Katarzyna ^{[1
]}

Czogala, Malgorzata ^{[3
]}

Balwierz, Walentyna ^{[3
]}

Skoczen, Szymon ^{[3
]}

Dobaczewski, Grzegorz ^{[4
]}

Chybicka, Alicja ^{[4
]}

Kalwak, Krzysztof ^{[4
]}

Krawczuk-Rybak, Maryna ^{[5
]}

Muszynska-Rostan, Katarzyna ^{[5
]}

Adamkiewicz-Droiynska, Elzbieta ^{[6
]}

Maciejka-Kapuscinska, Lucyna ^{[6
]}

Irga-Jaworska, Ninela ^{[6
]}

Pohorecka, Joanna ^{[7
]}

Chodata-Grzywacz, Agnieszka ^{[7
]}

Karolczyk, Graiyna ^{[7
]}

Wojcik, Beata ^{[7
]}

Kowalczyk, Jerzy R. ^{[8
]}

Drabko, Katarzyna ^{[8
]}

Zawitkowska, Joanna ^{[8
]}

Mycko, Katarzyna ^{[9
]}

Badowska, Wanda ^{[9
]}

Ociepa, Tomasz ^{[10
]}

Urasinski, Tomasz ^{[10
]}

Sikorska-Fic, Barbara ^{[11
]}

Matysiak, Michal ^{[11
]}

Laguna, Pawel ^{[11
]}

Dabrowska-Pawliszyn, Anna ^{[12
]}

Tomaszewska, Renata ^{[12
]}

Szczepanski, Tomasz ^{[12
]}

Sobol, Graiyna ^{[13
]}

Mizia-Malarz, Agnieszka ^{[13
]}

Ciebiera, Malgorzata ^{[14
]}

Chaber, Radoslaw ^{[14
]}

Koltan, Sylwia ^{[15
]}

Wysocki, Mariusz ^{[15
]}

Styczynski, Jan ^{[15
]}

Woszczyk, Mariola ^{[16
]}

Wieczorek, Maria ^{[16
]}

Karpinska-Derda, Irena ^{[16
]}

Urbanska-Rakus, Justyna ^{[16
]}

Bobeff, Katarzyna ^{[17
]}

Trelinska, Joanna ^{[17
]}

Mlynarski, Wojciech ^{[17
]}

机构：

[1] Univ Med Sci, Dept Pediat Hematol Oncol & TransplantolOncol & T, Poznan, Poland

[2] Univ Med Sci, Poznan, Poland

[3] Univ Children Hosp, Dept Pediat Oncol & Hematol, Krakow, Poland

[4] Wroclaw Med Univ, Clin Dept Pediat Bone Marrow Transplantat Oncol &, Wroclaw, Poland

[5] Med Univ, Dept Pediat Oncol & Hematol, Bialystok, Poland

[6] Med Univ, Dept Pediat Hematol & Oncol, Gdansk, Poland

[7] Reg Polyclin Hosp, Dept Pediat Hematol & Oncol, Kielce, Poland

[8] Med Univ, Dept Pediat Hematol Oncol & Transplantol, Lublin, Poland

[9] Prov Childrens Hosp, Dept Pediat & Hematol & Oncol, Olsztyn, Poland

[10] Pomeranian Med Univ, Dept Pediat HematoOncol & Gastroenterol, Szczecin, Poland

[11] Med Univ, Dept Oncol Pediat Hematol Transplantol & Pediat, Warsaw, Poland

[12] Silesian Univ Med, Dept Pediat Hematol & Oncol, Zabrze, Poland

[13] Med Univ Silesia, Katowice, Poland

[14] Clin Prov Hosp, Dept Pediat Oncohematol, Rzeszow, Poland

[15] Nicolaus Copernicus Univ Torun, Dept Pediat Hematol & Oncol, Coll Medicum, Bydgoszcz, Poland

[16] Pediat Ctr, Dept Pediat Hematol & Oncol, Chorzow, Poland

[17] Med Univ, Dept Pediat Oncol & Hematol, Lodz, Poland

[18] Uniwersytet Med Karola Marcinkowskiego, Klin Onkol Hematol & Transplantol Pediat, Poznan, Poland

来源：

WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY | 2023年 / 27卷 / 04期

关键词：

children; acute myeloid leukaemia; relapse; refractory; novel therapies; CHILDREN; RECOMMENDATIONS; CHEMOTHERAPY; CYTARABINE; MANAGEMENT; DIAGNOSIS;

D O I：

10.5114/wo.2023.135327

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Introduction: This study aimed to present the clinical features and results of treatment of patients diagnosed with refractory or relapsed acute myeloid leukaemia (AML) in Polish Paediatric Leukaemia/Lymphoma Study Group (PPL/LSG) institutions, treated in accordance with the Protocol Acute Myeloid Leukaemia Berlin -Frankfurt -Munster 2012, as their first -line therapy. Material and methods: The outcome data of 10 patients with refractory AML (median age 9.5 years) and 30 with relapsed AML (median age 12 years) were analysed retrospectively. Re -induction was usually based on idarubicin, fludarabine, and cytarabine along with allogeneic haematopoietic stem cell transplant (allo-HSCT) in 5 patients with refractory AML and 7 relapsed AML children. Results: 37.5% (3/8) of refractory AML patients achieved second complete remission second complete remission (CRII). One of ten patients (1/10; 10%) was alive and stayed in complete remission for 34 months after the allo-HSCT. The probability of 3 -year event -free survival (pEFS) in this group was 0.125 +/- 0.11. In the group of relapsed AML patients, the CRII was achieved in 9 patients (34%), and the probability of survival was: pEFS = 0.24 +/- 0.08; probability overall survival (pOS) = 0.34 +/- 0.09, with significantly better results achieved in patients who underwent allo-HSCT (pOS = 0.54 +/- 0.14 vs. 0.08 +/- 0.08, p < 0.0001). Conclusions: The prognosis of refractory AML and the first AML recurrence in children who were first -line treated in PPL/LSG centres according to Protocol Acute Myeloid Leukaemia Berlin -Frankfurt -Munster 2012 is poor. Failures of re -induction treatment particularly result from difficulties in achieving remission. Allogeneic HSCT improves prognosis in children with refractory and first recurrent AML, under the condition it is performed in complete remission. Novel therapeutic approaches are needed to increase the remission rate and improve the outcomes.

引用

页码：249 / 254

页数：6

共 50 条

[41] Outcomes of allogeneic haematopoietic stem cell transplantation for paediatric patients with MLL-rearranged acute myeloid leukaemia
Lu Bai
Yong-zhan Zhang
Chen-hua Yan
Yu Wang
Lan-ping Xu
Xiao-hui Zhang
Le-ping Zhang
Xiao-jun Huang
Yi-fei Cheng
BMC Cancer, 22
[42] Outcomes of allogeneic haematopoietic stem cell transplantation for paediatric patients with MLL-rearranged acute myeloid leukaemia
Bai, Lu
Zhang, Yong-zhan
Yan, Chen-hua
Wang, Yu
Xu, Lan-ping
Zhang, Xiao-hui
Zhang, Le-ping
Huang, Xiao-jun
Cheng, Yi-fei
BMC CANCER, 2022, 22 (01)
[43] Treatment and long-term results in children with acute myeloid leukaemia treated according to the AIEOP AML protocols
A Pession
R Rondelli
G Basso
C Rizzari
A M Testi
F Fagioli
P De Stefano
F Locatelli
Leukemia, 2005, 19 : 2043 - 2053
[44] Treatment and long-term results in children with acute myeloid leukaemia treated according to the AIEOP AML protocols
Pession, A
Rondelli, R
Basso, G
Rizzari, C
Testi, A
Fagioli, F
De Stefano, P
Locatelli, F
LEUKEMIA, 2005, 19 (12) : 2043 - 2053
[45] Clofarabine, cyclophosfamide, and Etoposide (CLOVE) treatment followed by SCT for relapsed or resistant acute leukaemia in paediatric patients
Miano, M.
Pistorio, A.
Putti, M. C.
Dufour, C.
Messina, C.
Barisone, E.
Ziino, O.
Parasole, R.
Luciani, M.
Lo Nigro, L.
Varotto, S.
Bertorello, N.
Calvillo, M.
Micalizzi, C.
BONE MARROW TRANSPLANTATION, 2011, 46 : S34 - S35
[46] A Phase II study of selinexor plus cytarabine and idarubicin in patients with relapsed/refractory acute myeloid leukaemia
Fiedler, Walter
Chromik, Joerg
Amberg, Stefanie
Kebenko, Maxim
Thol, Felicitas
Schlipfenbacher, Vera
Christine Wilke, Anne
Modemann, Franziska
Janning, Melanie
Serve, Hubert
Ganser, Arnold
Bokemeyer, Carsten
Theile, Susann
Deppermann, Ute
Kranich, Anne L.
Heuser, Michael
BRITISH JOURNAL OF HAEMATOLOGY, 2020, 190 (03) : E169 - E173
[47] Risk stratification therapy using response to initial treatment by AVC for paediatric acute myeloid leukaemia: a report from Japanese Children's Cancer Leukaemia Study Group (JCCLSG) AML 9805 Study
Taga, T.
Hori, T.
Horikoshi, Y.
Miyake, M.
Ogawa, A.
Chin, M.
Iizuka, S.
Kamitamari, A.
Itoh, M.
Sato, N.
Tsurusawa, M.
BRITISH JOURNAL OF HAEMATOLOGY, 2008, 141 : 102 - 103
[48] No significant prognostic value of normal precursor B-cell regeneration in paediatric acute myeloid leukaemia after induction treatment
Bras, Anne E.
van den Heuvel-Eibrink, Marry M.
van der Sluijs-Gelling, Alita J.
Coenen, Eva A.
Wind, Henk
Zwaan, C. Michel
te Marvel-de, Jeroen G.
van der Burg, Mirjam
Gibson, Brenda
Rijneveld, Anita W.
de Haas, Valerie
van Dongen, Jacques J. M.
van der Velden, Vincent H. J.
BRITISH JOURNAL OF HAEMATOLOGY, 2013, 161 (06) : 861 - 864
[49] CLOFARABINE, CYTARABINE AND MITOXANTRONE FOR RELAPSED OR REFRACTORY ACUTE MYELOID LEUKAEMIA - INTERIM RESULTS OF A PROSPECTIVE PHASE 2 STUDY
Gill, H.
Ip, H. W.
Yip, S. F.
Kho, B.
Lee, H.
Mak, V.
Lau, J.
Lau, C. K.
Lin, S. Y.
Wong, R.
Li, W.
Kwong, Y. L.
HAEMATOLOGICA, 2017, 102 : 677 - 677
[50] Genomic Imbalances Are Confined to Non-Proliferating Cells in Paediatric Patients with Acute Myeloid Leukaemia and a Normal or Incomplete Karyotype
Ballabio, Erica
Regan, Regina
Garimberti, Elisa
Harbott, Jochen
Bradtke, Jutta
Teigler-Schlegel, Andrea
Biondi, Andrea
Cazzaniga, Giovanni
Giudici, Giovanni
Wainscoat, James S.
Boultwood, Jacqueline
Bridger, Joanna M.
Knight, Samantha J. L.
Tosi, Sabrina
PLOS ONE, 2011, 6 (06):

← 1 2 3 4 5 →